title: Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer.
authors.affiliation: The CAS Key Laboratory of Innate Immunity and Chronic Disease, Hefei National Laboratory for Physical Sciences at the Microscale, School of Life Science and Medical Center, University of Science & Technology of China, Hefei, 230027, Anhui, P. R. China.
authors.forename: Dong
authors.initials: D
authors.lastname: Wang
authors.affiliation: The CAS Key Laboratory of Innate Immunity and Chronic Disease, Hefei National Laboratory for Physical Sciences at the Microscale, School of Life Science and Medical Center, University of Science & Technology of China, Hefei, 230027, Anhui, P. R. China.
authors.forename: Ruikai
authors.initials: R
authors.lastname: Du
authors.affiliation: Key Laboratory of Breast Cancer in Shanghai, Cancer Institute, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China. suling@fudan.edu.cn.|Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, P. R. China. suling@fudan.edu.cn.
authors.forename: Suling
authors.initials: S
authors.lastname: Liu
mesh_terms: D001940:Breast; D006801:Humans; D014411:Neoplastic Stem Cells; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D064726:Triple Negative Breast Neoplasms
chemical_list: D000067856:Poly(ADP-ribose) Polymerase Inhibitors